Pancuronium and deafness neurosensory Patient Reports February 13, 2012

Pancuronium Side Effects Report #5362646-6
Pancuronium side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2007. Female patient, child 5 years of age, was diagnosed with mechanical ventilation and was treated with Pancuronium. After drug was administered, patient experienced the following side effects: deafness neurosensory. Pancuronium dosage: unknown. During the same period patient was treated with DOPAMINE, DOBUTAMINE HYDROCHLORIDE, FENTANYL CITRATE, CALCIUM GLUCONATE, ALPROSTADIL, CEFMETAZOLE, CARBAZOCHROME SULFONATE. Patient recovered.

Pancuronium Side Effects Report #5362648-X
Pancuronium side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2007. Male patient, child 3 years of age, was diagnosed with mechanical ventilation and was treated with Pancuronium. After drug was administered, patient experienced the following side effects: deafness neurosensory, hearing aid user, renal failure acute, speech disorder developmental. Pancuronium dosage: 4.8 MG QD, INTRAVENOUS DRIP. During the same period patient was treated with CEFMETAZOLE, ULINASTATIN, FAMOTIDINE, DOBUTAMINE HYDROCHLORIDE, DOPAMINE, FENTANYL CITRATE, DEXAMETHASONE, BICARBONATE. Patient recovered.

Pancuronium Side Effects Report #5522892-5
Pancuronium side effect was reported by a Consumer or non-health professional from JAPAN on Nov 05, 2007. Male patient, 29 years of age, was diagnosed with mechanical ventilation and was treated with Pancuronium. After drug was administered, patient experienced the following side effects: deafness neurosensory. Pancuronium dosage: unknown. During the same period patient was treated with NITRIC OXIDE, GENTAMICIN. Patient recovered.

Pancuronium Side Effects Report #5362654-5
Pancuronium side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2007. Male patient was diagnosed with mechanical ventilation and was treated with Pancuronium. After drug was administered, patient experienced the following side effects: deafness neurosensory, gastrooesophageal reflux disease, hearing aid user, speech disorder developmental. Pancuronium dosage: unknown. During the same period patient was treated with MENATETRENONE, CARBAZOCHROME SULFONATE, TRANEXAMIC ACID, CALCIUM GLUCONATE, DEXAMETHASONE, CEFMETAZOLE, ULINASTATIN. Patient recovered.


Pancuronium Side Effects Report #4726259-9
Pancuronium side effect was reported by a Physician from JAPAN on July 14, 2005. Female patient, child 5 years of age, was diagnosed with life support and was treated with Pancuronium. After drug was administered, patient experienced the following side effects: deafness neurosensory. Pancuronium dosage: unknown. During the same period patient was treated with FENTANYL, NITROUS OXIDE, AMINOGLYCOSIDE, LOOP DIURETIC. Patient recovered.

Pancuronium Side Effects Report #4847479-9
Pancuronium side effect was reported by a Consumer or non-health professional from JAPAN on Nov 21, 2005. Female patient, child 5 years of age, was diagnosed with life support and was treated with Pancuronium. After drug was administered, patient experienced the following side effects: deafness neurosensory, hypoxia. Pancuronium dosage: unknown. During the same period patient was treated with DOPAMINE, DOBUTAMINE, FENTANYL CITRATE, CALCIUM GLUCONATE, ALPROSTADIL, CEFMETAZOLE, CARBAZOCHROME SULFONATE. Patient recovered.

Pancuronium Side Effects Report #4726260-5
Pancuronium side effect was reported by a Physician from JAPAN on July 14, 2005. Male patient, child 3 years of age, was diagnosed with life support and was treated with Pancuronium. After drug was administered, patient experienced the following side effects: deafness neurosensory, renal failure acute, speech disorder developmental. Pancuronium dosage: unknown. During the same period patient was treated with NITROUS OXIDE, LOOP DIURETIC. Patient recovered.

Pancuronium Side Effects Report #4847478-7
Pancuronium side effect was reported by a Health Professional from JAPAN on Nov 21, 2005. Male patient, child 3 years of age, was diagnosed with life support and was treated with Pancuronium. After drug was administered, patient experienced the following side effects: deafness neurosensory, renal failure acute, speech disorder developmental. Pancuronium dosage: 4.8 MG QD. During the same period patient was treated with CEPMETAZOLE, ULINASTATIN, FAMOTIDINE, DOBUTAMINE, DOPAMINE, FENTANYL CITRATE, DEXAMETHASONE, BICARBONATE. Patient recovered.

Pancuronium Side Effects Report #4847477-5
Pancuronium side effect was reported by a Consumer or non-health professional from JAPAN on Nov 21, 2005. Male patient was diagnosed with life support and was treated with Pancuronium. After drug was administered, patient experienced the following side effects: deafness neurosensory, speech disorder developmental. Pancuronium dosage: 0.3 MG S1HR/0.2 MG Q1HR. During the same period patient was treated with MENATETRENONE, CARBAZOCHROME SULFONATE, TRANEXAMIC ACID, CALCIUM GLUCONATE, DEXAMETHASONE, CEFMETAZOLE, ULINASTATIN. Patient recovered.


Pancuronium Side Effects Report #5936118-1
Pancuronium side effect was reported by a Consumer or non-health professional from JAPAN on Oct 15, 2008. Female patient was diagnosed with hypotonia and was treated with Pancuronium. After drug was administered, patient experienced the following side effects: deafness neurosensory, diaphragmatic hernia, disease recurrence, gastrointestinal perforation. Pancuronium dosage: unknown. During the same period patient was treated with PANCURONIUM BROMIDE, PANCURONIUM BROMIDE, DOPAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE, FENTANYL CITRATE, CHLORPROMAZINE, PROSTAGLANDIN F, OLPRINONE HYDROCHLORIDE. Patient recovered.